Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4541 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance

Read more ››
By: GlobeNewswire - 18 Mar 2024

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Read more ››
By: GlobeNewswire - 18 Mar 2024
Related companies:  Clearside Biomedical, Inc.

KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Shanghai Kechow Pharma, Inc.

Selvita launches biologic drug discovery and development services

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

The American Cancer Society and Color Health Announce Expansion of a Comprehensive Cancer Care Solution

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Color Health, Inc.

Dignify Therapeutics Announces Anthony DiTonno as Chief Executive Officer

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

EverGlade Funding Alert - ARPA-H Seeks Revolutionary Solutions for Precision Cancer Therapy Through ADAPT Program

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Samsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  BrickBio, Inc.

Syndax Announces Appointment of Steven Closter as Chief Commercial Officer

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Syndax Pharmaceuticals, Inc.

Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Leap Therapeutics, Inc.

PharmaCann Introduces Three New Brands to New York Market

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

CooperRiis Healing Community Introduces Direct Admission into Transitional Living Program

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Acurx Pharmaceuticals, LLC

Continuous Bioprocessing Market Worth $1,067.8 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Digital Surgery Technologies Market Worth $6.07 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Global Markets and Technologies for Advanced Drug Delivery Systems to Reach $359.1 Billion by 2028: BCC Research Analysis

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Global Digital Diagnostics Market Outlook 2024-2033: Increasing Opportunities for Digital Diagnostic Solutions in Emerging Economies - Featuring GE Healthcare, Siemens Healthineers, Medtronic, and More

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024

Spineart Secures more than CHF20 Million in Convertible Financing Following Completion of BAGUERA®C IDE Studies Enrollment

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Spineart SA

Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders

Read more ››
By: PR Newswire Association LLC. - 18 Mar 2024
Related companies:  Gabather AB
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑